What is the story about?
What's Happening?
The Collaborative Trajectory Analysis Project (cTAP) has announced the development of a novel prognostic score to predict the loss of ambulation in patients with Duchenne muscular dystrophy (DMD). This score, based on functional assessments like the rise
from floor and 10-meter walk/run, offers improved risk stratification and can aid in clinical decision-making and research.
Why It's Important?
This advancement is crucial for the management of DMD, a severe genetic disorder. The prognostic score allows for better patient counseling and trial design, potentially leading to more effective treatments. It represents a significant step forward in understanding and managing the disease, offering hope to patients and their families.
